DRACONIS PHARMA

ABOUT US

 

THE COMPANY

Draconis Pharma is a company that was founded in 2011 with the purpose of offering research and preclinical development services for novel treatments in the fields of inflammation and immunology. Our primary objective is to provide personalized testing services to our clients, allowing them to evaluate the capacity to modulate the immune response through bioassays using human primary cells or tissues. Additionally, we specialize in translating these findings into animal models of inflammatory diseases.
We employ various methods to characterize all experimental models ex-vivo, including the examination of immune cell profiles from different tissue samples using techniques such as flow cytometry, Luminex, or gene expression analysis.
To assess the biological characteristics of our treatments, we employ a tailored experimental design consisting of a battery of tests. These tests focus on studying the physicochemical properties, ADME (in vitro) properties, and pharmacokinetic properties (in vivo) of the treatments. Our bioanalytical platform supports these evaluations.

Furthermore, Draconis Pharma actively pursues strategic partnerships and collaboration agreements for the development of new technologies and therapies. We are committed to advancing the field of inflammation and immunology through innovation and cooperation.

STRATEGY

Draconis Pharma S.L. is focused on providing scientific and technological services to pharmaceutical and biotechnology companies, aimed at supporting drug discovery at different stages of research, such as target validation, hit-finding, hit-to-lead and lead optimization towards the release of a robust and well-characterized preclinical candidate. Our scientific team comes entirely from the pharmaceutical R&D industry.

Besides the service business, Draconis Pharma also participates in consortiums and projects for the discovery and development of innovative technology or novel therapies for the treatment of immune-related inflammatory diseases.

Daconis Pharma is not only a CRO